Trade Summary

2 days ago, BVF PARTNERS L P/IL, serving as See Remarks and Footnotes at Kymera Therapeutics, Inc. (KYMR), sold 1,630,658 shares at $106.50 per share, for a total transaction value of $173,665,077.00. Following this transaction, BVF PARTNERS L P/IL now holds 78,787 shares of KYMR.

This sale represents a 95.39% decrease in BVF PARTNERS L P/IL's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 26, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 26, 2026 at 6:48 PM ET, meaning the disclosure happened on the same day as the trade.

Kymera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.